AAAAAA

   
Results: 1-7 |
Results: 7
Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA
Authors: Orr, N Galen, JE Levine, MM
Citation: N. Orr et al., Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA, VACCINE, 19(13-14), 2001, pp. 1694-1700
Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated Delta guaBA Salmonella enterica serovar Typhi strain CVD 915
Authors: Wang, JY Pasetti, MF Noriega, FR Anderson, RJ Wasserman, SS Galen, JE Sztein, MB Levine, MM
Citation: Jy. Wang et al., Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated Delta guaBA Salmonella enterica serovar Typhi strain CVD 915, INFEC IMMUN, 69(8), 2001, pp. 4734-4741
Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosalvaccine against Shigella and ETEC infection
Authors: Altboum, Z Barry, EM Losonsky, G Galen, JE Levine, MM
Citation: Z. Altboum et al., Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosalvaccine against Shigella and ETEC infection, INFEC IMMUN, 69(5), 2001, pp. 3150-3158
Constitutive expression of the vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909
Authors: Wang, JY Noriega, FR Galen, JE Barry, E Levine, MM
Citation: Jy. Wang et al., Constitutive expression of the vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909, INFEC IMMUN, 68(8), 2000, pp. 4647-4652
In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar typhi strains as live mucosal vaccines and as live vectors
Authors: Pickett, TE Pasetti, MF Galen, JE Sztein, MB Levine, MM
Citation: Te. Pickett et al., In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar typhi strains as live mucosal vaccines and as live vectors, INFEC IMMUN, 68(1), 2000, pp. 205-213
Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM197, and its fragments in Salmonella typhi vaccine strain CVD 908-htrA
Authors: Orr, N Galen, JE Levine, MM
Citation: N. Orr et al., Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM197, and its fragments in Salmonella typhi vaccine strain CVD 908-htrA, INFEC IMMUN, 67(8), 1999, pp. 4290-4294
Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA
Authors: Galen, JE Nair, J Wang, JK Wasserman, SS Tanner, MK Sztein, MB Levine, MM
Citation: Je. Galen et al., Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA, INFEC IMMUN, 67(12), 1999, pp. 6424-6433
Risultati: 1-7 |